Showing results (1-10 of 51) with videos related to
Sort By:
Pageof 6
Therapeutic Delivery|July 27, 2012
Radioimmunotherapy: optimizing delivery to solid tumorsVineeth Rajkumar, Jason L Dearling, Alan Packard, et al.Cancer Biotherapy & Radiopharmaceuticals|August 3, 2004
Nonuniform absorbed dose distribution in the kidney: the influence of organ architectureAlan Green, Aiden Flynn, R Barbara Pedley, et al.NMR in Biomedicine|March 1, 2002
Differential sensitivity of two adenocarcinoma xenografts to the anti-vascular drugs combretastatin A4 phosphate and 5,6-dimethylxanthenone-4-acetic acid, assessed using MRI and MRSDaniel A Beauregard, R Barbara Pedley, Sally A Hill, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 26, 2019
Longitudinal Photoacoustic Imaging of the Pharmacodynamic Effect of Vascular Targeted Therapy on TumorsS Peter Johnson, Olumide Ogunlade, Mark F Lythgoe, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
Combining radioimmunotherapy with antihypoxia therapy 2-deoxy-D-glucose results in reduction of therapeutic efficacyJason L J Dearling, Uzma Qureshi, Richard H J Begent, et al.The Journal of Biological Chemistry|February 19, 2004
The Brn-3b transcription factor regulates the growth, behavior, and invasiveness of human neuroblastoma cells in vitro and in vivoShazia Irshad, R Barbara Pedley, John Anderson, et al.Journal of Labelled Compounds & Radiopharmaceuticals|December 19, 2013
Prospects for enhancement of targeted radionuclide therapy of cancer using ultrasoundRichard J Browning, Vineeth Rajkumar, R Barbara Pedley, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 27, 2012
A comparative study of PDGFR inhibition with imatinib on radiolabeled antibody targeting and clearance in two pathologically distinct models of colon adenocarcinomaVineeth S Rajkumar, Geoff Boxer, Mathew Robson, et al.Bioconjugate Chemistry|January 17, 2002
In vivo tumor delivery of a recombinant single chain Fv::tumor necrosis factor-alpha fusion [correction of factor: a fusion] proteinStephen P Cooke, R Barbara Pedley, R Boden, et al.British Journal of Cancer|October 21, 2015
Decomposition of spontaneous fluctuations in tumour oxygenation using BOLD MRI and independent component analysisMiguel R Gonçalves, S Peter Johnson, Rajiv Ramasawmy, et al.Pageof 6